Iradimed Corp. (IRMD) Tops Q3 EPS by 3c

Iradimed Corp. (NASDAQ: IRMD) reported Q3 EPS of $0.19, $0.03 better than the analyst estimate of $0.16. Revenue for the quarter came in at $8.2 million versus the consensus estimate of $7.7 million.

For earnings history and earnings-related data on Iradimed Corp. (IRMD) click here.

You May Also Be Interested In

• Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
• Primoris cuts 2026 outlook on renewables cost overruns, COO exits
• JPMorgan Starts ICICI Prudential Asset Management (ICICIAMC:IN) at Overweight